EP2790718
ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3
:
EP einkaleyfi: Þýðing ekki lögð inn:
12.12.2012:
7.2.2018:
12799204.8
:
11.12.2032
:
ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3
12.12.2012
7.2.2018
:
Institut National de la Santé et de la Recherche Médicale (INSERM):
101, rue de Tolbiac, 75013, Paris, FR
:
Université Paris Descartes:
12, rue de l'Ecole de Médecine, 75006, Paris, FR
:
Centre National de la Recherche Scientifique (C.N.R.S.):
3, rue Michel-Ange, 75016, Paris, FR
:
Assistance Publique Hôpitaux de Paris:
3 Avenue Victoria, 75004, Paris, FR
:
Université Paris Diderot - Paris 7:
5, rue Thomas Mann, 75013, Paris, FR
:
Imagine:
24, Boulevard du Montparnasse, 75015, Paris, FR
:
LEGEAI-MALLET, Laurence:
Paris, FR
:
MUNNICH, Arnold:
PARIS, FR
:
BUSCA, Patricia:
PARIS, FR
:
BARBAULT, Florent:
75205 PARIS Cedex 13, FR
:
PCT/IB2011/003253:
12.12.2011:
WO
:
EP2012075294:
12.12.2012
:
A61K 38/17, A61K 31/519, A61P 19/00, A61K 31/506